Fuller & Thaler Asset Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-44,625
Closed -$626K 609
2024
Q3
$626K Buy
+44,625
New +$494K ﹤0.01% 419
2020
Q2
Sell
-146,716
Closed -$1.53M 489
2020
Q1
$1.53M Buy
146,716
+12,941
+10% +$165K 0.03% 286
2019
Q4
$2.39M Buy
133,775
+375
+0.3% +$5.54K 0.03% 279
2019
Q3
$1.67M Buy
+133,400
New +$2.2M 0.02% 303

Other funds holding AXGN

Fuller & Thaler Asset Management's AXGN Position: Q4 2024 in Review

Fuller & Thaler Asset Management sold out of Axogen (AXGN) in Q4 2024, closing a stake of 44,625 shares — an estimated $626K sold.

Fuller & Thaler Asset Management first reported a position in AXGN in Q3 2019 and held it in 4 quarters. The position peaked at $2.39M in Q4 2019. 172 funds tracked by Wall St. Rank hold AXGN as of Q4 2024.

  • Fuller & Thaler Asset Management reported no remaining Axogen position as of Q4 2024 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 44,625 Axogen shares in Q4 2024, an estimated $626K.
  • Fuller & Thaler Asset Management first reported a position in Axogen in Q3 2019 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's Axogen position peaked at $2.39M in Q4 2019.
  • 172 funds tracked by Wall St. Rank held Axogen as of Q4 2024.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.